UroGen Pharma Ltd. ($URGN)
Filing Information
| Accession Number | 0001437749-26-029965 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
4,205
Total Value
$37,383.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Ordinary Shares | โ | Sep 7, 2026 | Exercise/Conversion | 1,667 | โ | โ | 60,753 | Direct | โ | View Details | |
Chief Medical Officer | Ordinary Shares | โ | Sep 8, 2026 | Sale | 871 | $42.92 | $37,383.32 | 59,882 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Sep 7, 2026 | Exercise/Conversion | 1,667 | $0.00 | $0.00 | 0 | Direct | โ | View Details |